Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
60 participants
INTERVENTIONAL
2022-02-28
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intralesional Treatment of Plantar Wart
NCT05057663
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
NCT05617950
Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts
NCT05520658
Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts
NCT05895071
Studying of Natural Constituents' Treatment of Plantar Warts
NCT05592041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Potassium hydroxide group
Patients with plantar warts will apply topical 30% potassium hydroxide solutions on warts
Topical 30%Potassium hydroxide solution
Patients will apply the solution every day under occlusion for 3 months
Hydrogen peroxide group
Patients with plantar warts will use topical 45% hydrogen peroxide solution on warts
Topical 45% hydrogen peroxide solution
Patients will apply the solution every day under occlusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topical 30%Potassium hydroxide solution
Patients will apply the solution every day under occlusion for 3 months
Topical 45% hydrogen peroxide solution
Patients will apply the solution every day under occlusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy and breastfeeding
* patients who receive immune suppressive therapy
* patients who received any wart treatments during the last 2 months before enrollent in the study
* patients who refused participation in the study
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samar Sayed Ahmed
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Samar Sa Ahmed, Resident
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sohag-Mes-21-11-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.